Nisa Investment Advisors LLC acquired a new position in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) in the 4th quarter, HoldingsChannel reports. The firm acquired 16,500 shares of the ...

View 10x Genomics, Inc. (TXG) current and estimated P/E ratio data provided by Seeking Alpha.

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...

The Honor Magic 7 Pro is an outstanding phone that impresses in almost every area. The screen is one of the best around, the performance is exceptional, and the battery lasts longer and charges ...

Realme hosted an event today to unveil the 14 Pro series for the international markets. Alongside the previously announced 14 Pro+, the 14 Pro was showcased with a lower price point but missing ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Leerink Partners analyst Puneet Souda has maintained their bullish stance on TXG stock, giving a Buy rating on January 13. Discover outperforming stocks and invest smarter with Top Smart Score ...

Investing.com -- Shares of 10X Genomics (NASDAQ:TXG) climbed 7% as the company reported preliminary fourth-quarter sales that surpassed analyst expectations. The life sciences company, known for its ...